MOLINARI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 4.462
EU - Europa 2.673
AS - Asia 2.591
SA - Sud America 407
AF - Africa 68
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.229
Nazione #
US - Stati Uniti d'America 4.359
IT - Italia 924
SG - Singapore 840
CN - Cina 642
GB - Regno Unito 467
VN - Vietnam 373
BR - Brasile 330
SE - Svezia 315
HK - Hong Kong 286
DE - Germania 245
RU - Federazione Russa 112
UA - Ucraina 99
FR - Francia 93
FI - Finlandia 87
KR - Corea 83
NL - Olanda 75
BD - Bangladesh 70
IN - India 65
CA - Canada 56
IE - Irlanda 47
ID - Indonesia 43
TR - Turchia 41
LT - Lituania 34
BE - Belgio 32
BG - Bulgaria 31
MX - Messico 31
AR - Argentina 26
AU - Australia 24
PL - Polonia 22
IQ - Iraq 21
ZA - Sudafrica 21
CZ - Repubblica Ceca 20
ES - Italia 18
JP - Giappone 18
PK - Pakistan 14
MY - Malesia 13
CO - Colombia 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
EC - Ecuador 10
TN - Tunisia 10
TW - Taiwan 10
CL - Cile 9
EG - Egitto 8
KE - Kenya 8
AT - Austria 7
CH - Svizzera 7
JO - Giordania 7
NO - Norvegia 7
UZ - Uzbekistan 7
MA - Marocco 6
PY - Paraguay 6
RS - Serbia 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
IL - Israele 4
IR - Iran 4
NG - Nigeria 4
PE - Perù 4
AZ - Azerbaigian 3
CR - Costa Rica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MD - Moldavia 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 10.220
Città #
Ashburn 529
Singapore 520
Santa Clara 442
Fairfield 316
Hong Kong 281
Chandler 248
Southend 248
San Jose 242
Woodbridge 213
Hefei 179
Ann Arbor 148
Nyköping 139
Modena 138
Houston 132
Wilmington 131
Ho Chi Minh City 124
Seattle 123
Los Angeles 121
New York 111
Beijing 110
Jacksonville 108
London 101
Council Bluffs 95
Dearborn 90
Cambridge 79
Hanoi 77
Seoul 72
Milan 69
The Dalles 62
Helsinki 58
Chicago 51
Bologna 45
Rome 43
Shanghai 43
Moscow 37
São Paulo 37
Dublin 34
San Diego 34
Munich 33
Jakarta 32
Sofia 30
Fremont 28
Princeton 28
Lauterbourg 26
Brussels 23
Da Nang 23
Buffalo 22
Dallas 21
Phoenix 21
Enschede 20
Orem 20
Salt Lake City 20
Toronto 20
Eugene 18
Izmir 18
Denver 17
Reggio Emilia 17
Haiphong 16
Chennai 15
Florence 15
Frankfurt am Main 15
Stockholm 15
Brno 14
Johannesburg 14
Montreal 14
Elk Grove Village 13
Tokyo 13
Warsaw 13
Columbus 12
Redwood City 12
Rio de Janeiro 12
Amsterdam 11
Atlanta 11
Bremen 11
Brooklyn 11
Mexico City 11
Dong Ket 10
Naples 10
Parma 10
Poplar 10
Turin 10
Biên Hòa 9
Boardman 9
Boston 9
Dhaka 9
Fuzhou 9
Grafing 9
Southwark 9
Bari 8
Belo Horizonte 8
Guarulhos 8
Kent 8
Mumbai 8
Amman 7
Des Moines 7
Hải Dương 7
Jinan 7
Kunming 7
New Delhi 7
Paris 7
Totale 6.517
Nome #
IL FATTORE DI TRASCRIZIONE MEF2C AI CROCEVIA TRA PROLIFERAZIONE, SVILUPPO E DIFFERENZIAMENTO MUSCOLARE 708
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 482
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 443
NF-YA splice variants have different roles on muscle differentiation 410
Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition 398
NF-Y splice variants differentially affect skeletal myogenesis 396
Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells 385
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 364
A novel complex regulates cardiac actin gene expression through interaction of Emb, a class VI POU domain protein, MEF2D, and the histone transacetylase p300 352
Alternative splicing of transcription factors genes in muscle physiology and pathology 344
PROLINE ISOMERASE PIN1 REPRESSES TERMINAL DIFFERENTIATION AND MYOCYTE ENHANCER FACTOR 2C FUNCTION IN SKELETAL MUSCLE CELLS 338
The in vivo form of the murine class VIPOU protein Emb is larger than that encoded by previously described transcripts 323
Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb. Ganassi M, Badodi S, Polacchini A, Baruffaldi F, Battini R, Hughes SM, Hinits Y, Molinari S. Biochim Biophys Acta. 2014 Jul;1839(7):559-70. doi: 10.1016/j.bbagrm.2014.05.003. Epub 2014 May 17. 311
A POTENTIAL ROLE OF MEF2C IN THE MYOGENIC PROGRESSION BESIDE TERMINAL DIFFERENTIATION 307
Proline Isomerase Pin1 represses terminal differentiation and Myocyte Enhancer Factor 2C function in Skeletal Muscle Cells 299
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 284
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 282
Regulation of Mef2c activity by alternative splicing in zebrafish muscle development 272
PIN1: a putative molecular target to protect skeletal muscle against age-related muscle loss 269
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 263
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 218
Induction of Calbindin-D28K by 1,25-dihydroxyvitamin D3 in cultured chicken intestinal cells 200
Metabolome in Tibialis and Soleus Muscles in Wild-Type and Pin1 Knockout Mice through High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy 194
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 189
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 187
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression 179
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 173
Differential response of embryonic and fetal myoblasts to TGF-beta. A possible regulatory mechanism of skeletal histogenesis 164
Absence of mef2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle 163
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 158
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 156
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 143
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 136
Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor 136
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 121
The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4 112
Phosphorylation-dependent binding of MEF2 to the A/T rich element in the muscle creatine kinase enhancer correlates with lack of expression in embryonic mammalian muscle 91
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 81
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 76
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 75
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 67
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 48
Totale 10.297
Categoria #
all - tutte 34.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022674 61 50 48 46 21 47 38 36 82 47 137 61
2022/2023821 94 107 57 92 59 103 31 76 81 25 45 51
2023/2024735 31 47 74 54 113 70 103 51 14 22 76 80
2024/20251.986 73 35 110 139 322 299 198 128 210 93 171 208
2025/20263.942 267 142 260 488 637 324 543 224 373 379 242 63
Totale 10.297